Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Safety, Tolerability, and Analgesic Efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01318369
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:28.734055+00:00
Published At
2013-07-09T00:00:00+00:00
Record Updated At
2013-07-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cannabinoid", "Tetrahydrocannabinol", "Chronic Pancreatitis", "Abdominal Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-07-09"
protocolSection.identificationModule.nctId
"NCT01318369"
protocolSection.identificationModule.officialTitle
"The Safety, Tolerability, and Analgesic Efficacy of \u03949-THC (Namisol\u00ae) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cannabinoid (protocolSection.conditionsModule.conditions)
  • Tetrahydrocannabinol (protocolSection.conditionsModule.conditions)
  • Chronic Pancreatitis (protocolSection.conditionsModule.conditions)
  • Abdominal Pain (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.